(Q42244116)

English

Anti-CD2 receptor and anti-CD2 ligand (CD48) antibodies synergize to prolong allograft survival

scientific article published on January 1994

Statements

Anti-CD2 receptor and anti-CD2 ligand (CD48) antibodies synergize to prolong allograft survival (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit